IL2 and cancer: Treatment of NK cells in culture with interleukins 2, 12, or 15 (IL-2, IL-12, IL-15) and interferon-α (IFN-α) can increase their cytotoxicity towards cancer cells and even toward cancer lines that are generally resistant to NK cell killing [145,146].